The U.S. infusion therapy device market will be driven by growth in the needleless connector market, which is expected to increase in value by over 50% during the forecast period.
In 2012, the U.S. market for infusion therapy devices was valued at just under $1.5 billion, a 3.2% increase over the previous year. This market includes infusion pumps, intravenous (IV) sets, and needleless connectors (NLCs). Infusion pumps are further segmented into large volume, syringe, patient-controlled analgesia (PCA), electronic ambulatory and disposable ambulatory infusion pumps. Growth in this market is expected to be driven by strong growth in the needleless connector market as the industry moves towards making procedures completely needle-free, and by growth in the disposable ambulatory infusion pump market as the number of infusion therapies performed in alternate or home care settings increases.
Scope: This report pertains to a forecast period of 10 years (2009 - 2019) for the U.S.
Reasons To Buy:
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our "bottom up" approach, which includes primary and secondary research methods.